Effect of Detecting and Isolating <i>Clostridium difficile</i> Carriers at Hospital Admission on the Incidence of <i>C difficile</i> Infections

Yves Longtin(Jewish General Hospital), Vivian G. Loo(McGill University Health Centre), Debby Ben-David(Sheba Medical Center), Jean Longtin(Centre hospitalier universitaire de Québec), Christophe Garenc(Institut National de Santé Publique du Québec), Bianka Paquet-Bolduc(Institut universitaire de cardiologie et de pneumologie de Québec), Simon Lévesque(Université de Sherbrooke), Sylvie Trottier, Jean-François Roussy(Centre hospitalier universitaire de Québec), Isabelle Cloutier(Montreal Heart Institute), Élise Fortin, Philippe Gervais(Centre hospitalier universitaire de Québec), Rodica Gilca(Centre hospitalier universitaire de Québec)
JAMA Internal Medicine
April 25, 2016
10.1001/jamainternmed.2016.0177
Cited by 213

Related Papers

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2017|2.7k
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2018|1.2k
A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory
|PLoS ONE|2015|172
Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.
|The EMBO Journal|1996|143
Detection and Quantification of Airborne Norovirus During Outbreaks in Healthcare Facilities
|Clinical Infectious Diseases|2015|116